Jumat, 18 Mei 2012

Anxiety Disorders And Cellular Metabolism Linked

Anxiety Disorders And Cellular Metabolism Linked

Editor's Choice
Main Category: Anxiety / Stress
Also Included In: Genetics
Article Date: 18 May 2012 - 15:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions   <!-- rate icon rate article
Patient / Public:not yet rated

Healthcare Prof:not yet rated


Researchers at the University of Chicago have found an association between anxiety disorders and the gene that encodes Glyoxylase 1 (GLO1). However, the mechanism underlying this association is unclear.

The most prevalent psychiatric diseases in the United States are anxiety disorders, which range from post-traumatic stress disorder to social phobia.

Using a mouse model, Margaret Distler and her team set out to determine whether the primary substrate of GlO1, methylglyoxal, might have unproven neurological effects.

The normal role of GLO1 is to degrade cytotoxic byproducts of glycolysis, a function which has no clear association to anxiety.

The researchers found that methyglyoxal stimulates robust activity from GABAA receptors (neuron receptors that respond to neurotransmitters).

At present, pharmaceuticals focus on GABAA receptors as their main target for anxiety treatments. However, this study demonstrates that a definitive working link exists between anxiety and GLO1 activity.

In addition, the team found that preventing GLO1 reduced anxious behavior in mice, indicating that GLO1 may be a potential new treatment target in humans. According to the researchers, findings from the study are important not only for anxiety disorders, but also for other nervous system diseases linked with GLO1, including schizophrenia, affective disorders, and autism.

Written By Grace Rattue
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

"Glyoxalase 1 increases anxiety by reducing GABAA receptor agonist methylglyoxal"
Margaret G. Distler, Leigh D. Plant, Greta Sokoloff, Andrew J. Hawk, Ivy Aneas, Gerald E. Wuenschell, John Termini, Stephen C. Meredith, Marcelo A. Nobrega and Abraham A. Palmer
The Journal of Clinical Investigation , May 2012, doi: 10.1172/JCI61319 Please use one of the following formats to cite this article in your essay, paper or report:

MLA


APA

Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

'Anxiety Disorders And Cellular Metabolism Linked'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



MediLexicon International Ltd Logo

Privacy Policy | Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.

Everyday Health Network back to top | home | privacy policy

MediLexicon International Ltd Logo MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.

Tidak ada komentar:

Posting Komentar